Memorial Sloan Kettering's Blood and Marrow Transplant Program
BMT Core - MSK
This program helps patients with serious blood disorders by participating in a national network that tests new ways to improve blood and bone marrow transplants and other cell therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11170516 on NIH RePORTER |
What this research studies
Memorial Sloan Kettering Cancer Center (MSK) is a major participant in the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). This means MSK helps conduct multi-center clinical trials to find better treatments for life-threatening blood disorders. Their program, which includes both adult and pediatric services, is highly accredited for both hematopoietic cell transplants and immune cell therapies. By being a core center, MSK contributes to the network's mission to improve patient outcomes through advanced research.
Who could benefit from this research
Good fit: Patients facing life-threatening blood disorders who are candidates for blood, bone marrow, or other cellular therapies, including both children and adults, may be considered.
Not a fit: Patients who do not have blood disorders requiring transplantation or cellular therapy would not directly benefit from this specific program.
Why it matters
Potential benefit: Patients with life-threatening blood disorders could benefit from access to cutting-edge treatments and improved outcomes through participation in clinical trials supported by this core.
How similar studies have performed: The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) has a long history of conducting successful multi-institutional clinical trials, building on established approaches.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Perales, Miguel-Angel — Sloan-Kettering Inst Can Research
- Study coordinator: Perales, Miguel-Angel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.